MTOR and metabolic dysfunction-associated steatohepatitis: In summary, our findings provide evidence that the altered AKT/mTOR signaling cascades, increased glycolysis, enhanced de novo lipogenesis and fat uptake, and heightened inflammation, all together contributed to the development of NASH-related HCC in WT mice.